Special Issue "Molecular Research on Polycystic Ovary Syndrome (PCOS) 2.0"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 12892
Interests: embryogenesis; in vitro fertilization; oxidative stress; inflammation; endometriosis; polycystic ovarian syndrome
Special Issues, Collections and Topics in MDPI journals
Polycystic ovarian syndrome (PCOS) is one of the most prevalent endocrine disorders affecting women of reproductive age, which negatively affects the quality of life and psychological wellbeing. Hyperandrogenism, chronic anovulation, and polycystic ovaries have been associated with an increased risk of infertility, but also with metabolic alterations, including insulin resistance and hyperinsulinism, type 2 diabetes mellitus, dyslipidemia, cardiovascular disease, and endometrial carcinoma.
PCOS is a polygenic and multifactorial syndromic disorder. Despite progress in its diagnosis and management, little is known about the molecular mechanisms and signaling pathways underlying the pathogenic mechanisms. In this sense, recent research has suggested that the influence of multiple factors, including age, environment, lifestyle, and disease state environment, can change the clinical presentation of PCOS via epigenetic modifications.
This Special Issue will emphasize the molecular mechanisms and signaling pathways related to the development and progression of PCOS. Research mechanisms by which variants in the genes confer risk to PCOS and the interaction between the genetic and environmental elements will be of great interest, too. Finally, this issue will also discuss clinical studies and novel therapeutic approaches in PCOS treatment. We welcome original manuscripts and review articles addressing this topic.
Prof. Dr. Paolo Giovanni Artini
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- polycystic ovary syndrome
- ovarian steroidogenesis
- insulin resistance
- chronic inflammation
- genetic predisposition
- epigenetic mechanisms
- Molecular Research on Polycystic Ovary Syndrome (PCOS) in Biomedicines (18 articles)